In our study, we found that NAT10-mediated Ac4C modification, rather than m6A modification, plays a crucial role in maintaining the stability of LINC02802, which partially explains the upregulation of LINC02802 in NSCLC. The gene discussed is NAT10; the disease is non-small cell lung carcinoma.